Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by Sailboatdreamon Oct 12, 2022 2:00pm
276 Views
Post# 35020150

RE:RE:RE:Ruminations on tribulations and communications

RE:RE:RE:Ruminations on tribulations and communications

Agreed.  Only way forward is a buy-out.  Not sure Philip has the profile or detachment necessary to orchestrate a suitable buy-out.  In fact, market is already answering that question.


BioTeck wrote: There is nooooooo way the company as it stands today could generate profit and run as a business.  I think the only good employees the company has are the ones in the lab. The rest all the way from the multiple contracted IR to the CFO all the way to the board are completely useless. They don't even buy a single share of the company when it's beat up and just get fat off options and do nothing to deserve them. Let's take my favorite moustache man. Phil did the entire deal with Evotec, what exactly has moustache man done to deserve all the options he got? Hasn't even spoke at an AGM, conference, mentioned in a news release, NADA. As far as I'm concerned he is dead weight. Don't even get me started on our CFO who got 5 MILLION shares for doing what exactly? Filing a tax return.

Can't  blame the actors but can blame the person who put them there and is OK with them doing the bare minimum. I guess when you're a micro manager, you look for people who are lazy and don't want to do anything unless they are told to do it. Deal by a thousand cuts will be the end of this company if something doesn't change. 

 

<< Previous
Bullboard Posts
Next >>